The global market for drug discovery technologies was valued at $100.3 billion in 2023 and is projected to reach $197.3 billion by the end of 2029, at a 12.0% CAGR for the forecast period.
People with rheumatoid arthritis often develop osteoporosis, a more serious condition, as a result of the bone damage caused by immune cells and as a side effect of certain medications.